"But eventually, when you avoid change and risk for so long - the lack of it, can actually become the risk itself." 👏👏👏
So agreed! Dana Lewis, who has type 1 diabetes and is one of the inventors of the open-source artificial pancreas system, has written about this concept when applied to diabetes technology. https://onlinelibrary.wiley.com/doi/10.1111/dme.14687
"The safety conversation should also include a discussion of errors of omission or commission. Healthcare providers and regulators may prefer to approach risk with a policy of 'don't add a new thing if it adds risk or harm' (to minimize the risks of committing an error of commission). But doing that when the safety benefits would exceed the added risks yields a greater error of omission, and creates clinical inertia. When you know based on available data that commercial and open source automated insulin delivery systems are safer and more effective than manually dosing insulin, refusing to discuss these systems or trying to block patients from using these systems becomes an error of omission."
Things will change when individual medical professionals believe they will be better compensated (money+impact+status) by working in healthtech than as traditionally trained clinicians.
Favorite read of the year 💪🏼 Hit so many nails on the head.. although so many sad truths to swallow
Emily, I cannot tell you how inspirational of a read this is. Thank you. Yisha
"But eventually, when you avoid change and risk for so long - the lack of it, can actually become the risk itself." 👏👏👏
So agreed! Dana Lewis, who has type 1 diabetes and is one of the inventors of the open-source artificial pancreas system, has written about this concept when applied to diabetes technology. https://onlinelibrary.wiley.com/doi/10.1111/dme.14687
"The safety conversation should also include a discussion of errors of omission or commission. Healthcare providers and regulators may prefer to approach risk with a policy of 'don't add a new thing if it adds risk or harm' (to minimize the risks of committing an error of commission). But doing that when the safety benefits would exceed the added risks yields a greater error of omission, and creates clinical inertia. When you know based on available data that commercial and open source automated insulin delivery systems are safer and more effective than manually dosing insulin, refusing to discuss these systems or trying to block patients from using these systems becomes an error of omission."
Emily, Spot on! We should to talk. I would love to learn more about your mission and share mine. I expect we might find ways to collaborate.
Let’s connect on LinkedIn:
https://www.linkedin.com/in/pjstevenson
Things will change when individual medical professionals believe they will be better compensated (money+impact+status) by working in healthtech than as traditionally trained clinicians.
Brilliant article! Thanks Emily!